Works about EVEROLIMUS

Results: 1054

Sequential molecularly targeted drug therapy including axitinib for a patient with end-stage renal failure and metastatic renal cell carcinoma.

Published in:

2016

By:

Hayato NISHIDA;
Hiroki FUKUHARA;
Atsushi YAMAGISHI;
Toshihiko SAKURAI;
Tomohiro SHIBASAKI;
Hisashi KAWAZOE;
Tomoyuki KATO;
Yoshihiko TOMITA

Publication type:

Case Study

Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization.

Published in:

United European Gastroenterology Journal, 2025, v. 13, n. 1, p. 34, doi. 10.1002/ueg2.12710

By:

Tacelli, Matteo;
Partelli, Stefano;
Falconi, Massimo;
Arcidiacono, Paolo Giorgio;
Capurso, Gabriele

Publication type:

Article

Is rapamycin a rapalog?

Published in:

Nutrition & Healthy Aging, 2019, v. 5, n. 1, p. 21, doi. 10.3233/NHA-180045

By:

Glass, David J.;
Lamming, Dudley W.

Publication type:

Article

One-year Clinical Outcomes of Biodegradable Polymer Coated Everolimus-eluting Coronary Stent: Results from a Prospective, Open-label, Non-randomized Study.

Published in:

Indian Journal of Clinical Cardiology, 2025, v. 6, n. 2, p. 181, doi. 10.1177/26324636251321226

By:

Kasturi, Sridhar;
Singh, Shailender;
Reddy, Vijay Kumar;
Pratap, Vikram;
Masalawala, Abhishek;
Misra, Anil Kumar

Publication type:

Article

Autoimmune Hemolytic Anemia Following Kidney Transplant: The Role of Tacrolimus and Transition to Everolimus in a Pediatric Case.

Published in:

Pediatric Transplantation, 2025, v. 29, n. 4, p. 1, doi. 10.1111/petr.70104

By:

Al Riyami, Mohamed S.;
Al Gaithi, Badria;
Al Alawi, Intisar;
Al Maskari, Anisa;
Al Kalbani, Naifain;
Al Saidi, Suliman

Publication type:

Article

Precision Monitoring of Immunosuppressive Agent Concentrations in Cardiac Tissue of Pediatric Heart Transplant Recipients.

Published in:

Pediatric Transplantation, 2025, v. 29, n. 4, p. 1, doi. 10.1111/petr.70092

By:

Hashimoto, Kazuhisa;
Kimura, Natsuka;
Narita, Jun;
Ishii, Ryo;
Hirose, Masaki;
Hayashi, Ken;
Nishino, Haruka;
Ueyama, Atsuko;
Ueda, Kazutoshi;
Yoshihara, Chika;
Kitabatake, Yasuji;
Nagai, Ryozo;
Aizawa, Kenichi;
Ishida, Hidekazu

Publication type:

Article

Histoplasmosis After Liver Transplantation—a Skate on Thin Ice if Left Undiagnosed.

Published in:

Indian Journal of Surgery, 2020, v. 82, n. 4, p. 695, doi. 10.1007/s12262-019-02048-2

By:

Maharaj, Rajiv;
Kapoor, Dharmesh;
Dekate, Jyoti;
Singh, Balbir;
Venugopal, K.;
Nathani, Priya

Publication type:

Article

High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal Transplantation.

Published in:

Journal of Women's Health (15409996), 2018, v. 27, n. 3, p. 394, doi. 10.1089/jwh.2017.6451

By:

Bachmann, Friederike;
Glander, Petra;
Budde, Klemens;
Bachmann, Cornelia

Publication type:

Article

Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 12, p. 1667, doi. 10.1007/s00228-020-02968-z

By:

Veenhof, Herman;
Schouw, Hugo M.;
Besouw, Martine T. P.;
Touw, Daan J.;
Gracchi, Valentina

Publication type:

Article

m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 11, p. 1471, doi. 10.1007/s00228-019-02730-0

By:

Ghadimi, Maryam;
Mohammadpour, Zinat;
Dashti-Khavidaki, Simin;
Milajerdi, Alireza

Publication type:

Article

Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 4, p. 465, doi. 10.1007/s00228-017-2394-0

By:

Willemsen, A. E. C. A. B.;
Knapen, L. M.;
de Beer, Y. M.;
Brüggemann, R. J. M.;
Croes, S.;
van Herpen, C. M. L.;
van Erp, N. P.

Publication type:

Article

The Efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.

Published in:

2021

By:

Wei, Chang-Ching;
Hsiao, Yu-Ping;
Gau, Shuo-Yan;
Wu, Yue-Ting;
Wu, Chi-Tang;
Wu, Meng-Hsuan;
Tsai, Jeng-Dau

Publication type:

journal article

Everolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in Small Coronary Artery Intervention.

Published in:

Zagazig University Medical Journal, 2023, v. 29, p. 194, doi. 10.21608/zumj.2020.47265.1977

By:

Metwally, Yasser G.;
Elnady, Khaled Y.;
Swailem, Fathy M.

Publication type:

Article

BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancer.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01027-8

By:

Shao, Zhi-Ming;
Cai, Li;
Wang, Shusen;
Hu, Xichun;
Shen, Kunwei;
Wang, Haibo;
Li, Huiping;
Feng, Jifeng;
Liu, Qiang;
Cheng, Jing;
Wu, Xinhong;
Wang, Xiaojia;
Li, Hongyuan;
Luo, Ting;
Liu, Jinping;
Amin, Khalid;
Slimane, Khemaies;
Qiao, Yongping;
Liu, Yongmin;
Tong, Zhongsheng

Publication type:

Article

The effects of lithium, metformin and everolimus substances on cell growth in 2D and 3D Ishikawa endometrial carcinoma cell culture.

Published in:

Pamukkale Medical Journal, 2024, v. 17, n. 3, p. 560, doi. 10.31362/patd.1490977

By:

Tural, Emine;
Çil, Nazlı;
Seçme, Mücahit;
Mete, Gülçin Abban;
Darıcı, Hakan;
Bilir, Ayhan;
Karaöz, Erdal

Publication type:

Article

Adjuvant Everolimus in Non–Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.

Published in:

JAMA Network Open, 2024, v. 7, n. 8, p. e2425288, doi. 10.1001/jamanetworkopen.2024.25288

By:

Gulati, Shuchi;
Tangen, Catherine;
Ryan, Christopher W.;
Vaishampayan, Ulka N.;
Shuch, Brian M.;
Barata, Pedro C.;
Pruthi, Deepak K.;
Bergerot, Cristiane D.;
Tripathi, Abhishek;
Lerner, Seth P.;
Thompson Jr, Ian M.;
Lara Jr, Primo N.;
Pal, Sumanta K.

Publication type:

Article

Adjuvant Therapy for Non–Clear Cell Renal Cell Carcinoma—The Ascent Continues.

Published in:

2024

By:

Brown, Jacqueline T.

Publication type:

Opinion

Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 232, doi. 10.3390/jcm8020232

By:

Cerni, Stephen;
Shafer, Dylan;
To, Kimberly;
Venketaraman, Vishwanath

Publication type:

Article

Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.

Published in:

Vascular & Endovascular Surgery, 2017, v. 51, n. 2, p. 60, doi. 10.1177/1538574416689429

By:

Giaquinta, Alessia;
Vincenzo, Ardita;
De Marco, Ester;
Veroux, Massimiliano;
Veroux, Pierfrancesco

Publication type:

Article

EFFECTS OF DIFFERENT DRUG BINDING IN STENTED POROUS ARTERY TISSUEWALL: A NUMERICAL MODEL STUDY.

Published in:

Palestine Journal of Mathematics, 2022, v. 11, p. 84

By:

Saha, Ramprosad

Publication type:

Article

Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders.

Published in:

Annals of Clinical & Translational Neurology, 2017, v. 4, n. 12, p. 877, doi. 10.1002/acn3.494

By:

Krueger, Darcy A.;
Sadhwani, Anjali;
Byars, Anna W.;
Vries, Petrus J.;
Franz, David N.;
Whittemore, Vicky H.;
Filip‐Dhima, Rajna;
Murray, Donna;
Kapur, Kush;
Sahin, Mustafa

Publication type:

Article

Inhibitor for protein disulfide-isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16.

Published in:

Oncology Letters, 2021, v. 21, n. 1, p. N.PAG

By:

Kaneya, Yohei;
Takata, Hideyuki;
Wada, Ryuichi;
Kure, Shoko;
Ishino, Kousuke;
Kudo, Mitsuhiro;
Kondo, Ryota;
Taniai, Nobuhiko;
Ohashi, Ryuji;
Yoshida, Hiroshi;
Naito, Zenya

Publication type:

Article

Everolimus inhibits the proliferation and migration of epidermal growth factor receptor-resistant lung cancer cells A549 via regulating the microRNA-4328/phosphatase and tensin homolog signaling pathway.

Published in:

Oncology Letters, 2019, v. 18, n. 5, p. 5269, doi. 10.3892/ol.2019.10887

By:

Xiang, Xudong;
Zhuang, Li;
Chen, Huicheng;
Yang, Xiumei;
Li, Heng;
Li, Gaofeng;
Yu, Jing

Publication type:

Article

Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells.

Published in:

Oncology Letters, 2017, v. 14, n. 3, p. 3832, doi. 10.3892/ol.2017.6597

By:

Taglieri, Ludovica;
De Iuliis, Francesca;
Giuffrida, Anna;
Giantulli, Sabrina;
Silvestri, Ida;
Scarpa, Susanna

Publication type:

Article

Long-term remission of hormone receptor-positive/HER2-positive metastatic breast cancer due to combined treatment with everolimus/trastuzumab/exemestane: A case report.

Published in:

2017

By:

JIAN WANG;
CHUNXIAO SUN;
XIANG HUANG;
JINRONG QIU;
YONGMEI YIN

Publication type:

Case Study

MED23 in endocrinotherapy for breast cancer.

Published in:

Oncology Letters, 2017, v. 13, n. 6, p. 4679, doi. 10.3892/ol.2017.6036

By:

BENRUI LIN;
LAN ZHANG;
DINUO LI;
HONGZHI SUN

Publication type:

Article

Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review.

Published in:

Oncology Letters, 2016, v. 12, n. 6, p. 4739, doi. 10.3892/ol.2016.5231

By:

FLECHTER, EZEQUIEL;
ZOHAR, YANIV;
GURALNIK, LUDMILA;
PASSHAK, MARIA;
SELA, GIL BAR

Publication type:

Article

Histological complete response with nivolumab for renal cell carcinoma with multiple metastases: A case report.

Published in:

Molecular & Clinical Oncology, 2019, v. 10, n. 2, p. 244

By:

Shirotake, Suguru;
Kaneko, Go;
Nagata, Koji;
Oyama, Masafumi;
Nishimoto, Koshiro

Publication type:

Article

Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional study.

Published in:

Molecular & Clinical Oncology, 2019, v. 10, n. 1, p. 125

By:

Shirotake, Suguru;
Kondo, Hideyuki;
Okabe, Takashi;
Makino, Soichi;
Araki, Ryuichiro;
Komatsuda, Akari;
Kaneko, Go;
Nishimoto, Koshiro;
Oyama, Masafumi

Publication type:

Article

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.

Published in:

Molecular & Clinical Oncology, 2018, v. 9, n. 3, p. 255, doi. 10.3892/mco.2018.1672

By:

Riccardi, Ferdinando;
Colantuoni, Giuseppe;
Diana, Anna;
Mocerino, Carmela;
Cartenì, Giacomo;
Lauria, Rossella;
Febbraro, Antonio;
Nuzzo, Francesco;
Addeo, Raffaele;
Marano, Ombretta;
Incoronato, Pasquale;
De Placido, Sabino;
Ciardiello, Fortunato;
Orditura, Michele

Publication type:

Article

Osteonecrosis of the jaw associated with everolimus: A case report.

Published in:

Molecular & Clinical Oncology, 2017, v. 6, n. 2, p. 255, doi. 10.3892/mco.2016.1100

By:

DAIGO YAMAMOTO;
YU TSUBOTA;
TOSHIKI UTSUNOMIYA;
NORIKO SUEOKA;
AIKO UEDA;
KAYOKO ENDO;
KATSUHIRO YOSHIKAWA;
MASANORI KON

Publication type:

Article

Significant cytostatic effect of everolimus on a gefitinib-resistant anaplastic thyroid cancer cell line harboring PI3KCA gene mutation.

Published in:

Molecular & Clinical Oncology, 2015, v. 3, n. 3, p. 522, doi. 10.3892/mco.2015.496

By:

ONODA, NAOYOSHI;
NAKAMURA, MASANORI;
AOMATSU, NAOKI;
NODA, SATORU;
KASHIWAGI, SHINICHIRO;
KURATA, KENTO;
UCHINO, SHINYA;
HIRAKAWA, KOSEI

Publication type:

Article

Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up<sup>1</sup>.

Published in:

Clinical Hemorheology & Microcirculation, 2018, v. 69, n. 1-2, p. 3, doi. 10.3233/CH-189101

By:

Anadol, Remzi;
Dimitriadis, Zisis;
Polimeni, Alberto;
Wendling, Franziska;
Gönner, Svenja;
Ullrich, Helen;
Lorenz, Liv;
Weissner, Melissa;
Munzel, Thomas;
Gori, Tommaso

Publication type:

Article

Léčba oboustranných objemných angiomyolipomů ledviny everolimem.

Published in:

Czech Urology / Ceska Urologie, 2024, v. 28, n. 2, p. 113

By:

Blažková, Kristýna;
Šámal, Vladimír;
Richter, Igor;
Paldus, Vít

Publication type:

Article

Comparative Vascular Effects of Sirolimus and Everolimus on Isolated Human Saphenous Veins.

Published in:

Life (2075-1729), 2025, v. 15, n. 4, p. 553, doi. 10.3390/life15040553

By:

Kaleli Durman, Deniz;
Civelek, Erkan;
Alp Yildirim, Fatoş İlkay;
Teskin, Önder;
Uydeş Doğan, Birsel Sönmez

Publication type:

Article

Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation.

Published in:

Life (2075-1729), 2024, v. 14, n. 5, p. 603, doi. 10.3390/life14050603

By:

Iturbe-Fernández, David;
de Pablo Gafas, Alicia;
Mora Cuesta, Víctor Manuel;
Alonso Moralejo, Rodrigo;
Quezada Loaiza, Carlos Andrés;
Pérez González, Virginia;
López-Padilla, Daniel;
Cifrián, José M.

Publication type:

Article

Safety and Efficacy of an Innovative Everolimus-Coated Balloon in a Swine Coronary Artery Model.

Published in:

Life (2075-1729), 2023, v. 13, n. 10, p. 2053, doi. 10.3390/life13102053

By:

Katsouras, Christos S.;
Tousis, Alexandros;
Vasilagkos, Georgios;
Semertzioglou, Arsen;
Vratimos, Athanassios;
Samara, Ioanna;
Karanasiou, Georgia;
Loukas, Vasileios S.;
Tsigkas, Grigorios;
Fotiadis, Dimitrios;
Michalis, Lampros K.;
Davlouros, Periklis;
Moulas, Anargyros N.

Publication type:

Article

Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8<sup>+</sup> T and NK Cells in Heart Transplant Patients.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02181

By:

Díaz-Molina, Beatriz;
Diaz-Bulnes, Paula;
Carvajal Palao, Reyes;
Bernardo, Maria José;
Rodriguez, Ramón M.;
Corte-Iglesias, Viviana;
Moris de la Tassa, Cesar;
Lambert, Jose Luis;
Suarez-Alvarez, Beatriz

Publication type:

Article

Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs).

Published in:

Clinical Kidney Journal, 2014, v. 7, n. 2, p. 115, doi. 10.1093/ckj/sfu001

By:

Gharbi, Chems;
Gueutin, Victor;
Izzedine, Hassan

Publication type:

Article

Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 11, p. 1412, doi. 10.1038/bmt.2014.170

By:

Mielke, S;
Lutz, M;
Schmidhuber, J;
Kapp, M;
Ditz, D;
Ammer, J;
Einsele, H;
Grigoleit, G U;
Holler, E;
Wolff, D

Publication type:

Article

Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 608, doi. 10.1111/ced.15018

By:

Gambichler, T.;
Hessam, S.;
Lüttringhaus, T.;
Boms, S.

Publication type:

Article

The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.

Published in:

Drugs, 2016, v. 76, n. 5, p. 551, doi. 10.1007/s40265-016-0552-9

By:

Curatolo, Paolo;
Bjørnvold, Marit;
Dill, Patricia;
Ferreira, José;
Feucht, Martha;
Hertzberg, Christoph;
Jansen, Anna;
Jóźwiak, Sergiusz;
Kingswood, J.;
Kotulska, Katarzyna;
Macaya, Alfons;
Moavero, Romina;
Nabbout, Rima;
Zonnenberg, Bernard

Publication type:

Article

Small bowel tuberculosis causing massive obscure gastrointestinal bleeding in an immunocompromised patient.

Published in:

2015

By:

Sharma, Vishal;
Rana, Surinder S.;
Dhaka, Narendra;
Saikia, Uma Nahar;
Hemanth, Kumar K.;
Gupta, Rajesh;
Bhasin, Deepak K.

Publication type:

Case Study

Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers.

Published in:

Clinical Pharmacology, 2015, v. 7, p. 11, doi. 10.2147/CPAA.S73472

By:

Thudium, Karen;
Gallo, Jorge;
Bouillaud, Emmanuel;
Sachs, Carolin;
Eddy, Simantini;
Wing Cheung

Publication type:

Article

Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma.

Published in:

Genes, 2022, v. 13, n. 7, p. 1211, doi. 10.3390/genes13071211

By:

Hong, Seong-Hwi;
Lee, Kwang-Suk;
Hwang, Hyun-Ji;
Park, Sung-Yul;
Han, Woong-Kyu;
Yoon, Young-Eun

Publication type:

Article

Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review.

Published in:

Pediatric Reports, 2021, v. 13, n. 1, p. 104, doi. 10.3390/pediatric13010015

By:

Nespoli, Luisa Federica;
Albani, Elena;
Corti, Carla;
Spaccini, Luigina;
Alfei, Enrico;
Daniele, Irene;
Zuccotti, Gian Vincenzo;
Lista, Gianluca;
Calcaterra, Valeria;
Mannarino, Savina

Publication type:

Article

Assessment of efficacy of 5% topical amlexanox and 0.1% topical triamcinolone acetonide in management of recurrent aphthous stomatitis.

Published in:

Journal of Pharmacy & Bioallied Sciences, 2020, v. 12, p. 444, doi. 10.4103/jpbs.JPBS_133_20

By:

Kavita, Kumari;
Singh, Rohit;
Singh, Revati;
Gonuguntla, Sudhir;
Luke, Alexander;
Jois, Harshvardhan

Publication type:

Article

Evaluating Elacestrant in the Management of ER-Positive, HER2-Negative Advanced Breast Cancer: Evidence to Date.

Published in:

OncoTargets & Therapy, 2023, v. 16, p. 189, doi. 10.2147/OTT.S400563

By:

Varella, Leticia;
Cristofanilli, Massimo

Publication type:

Article

Efficient Everolimus Treatment for Metastatic Castration Resistant Prostate Cancer with AKT1 Mutation: A Case Report.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 5423, doi. 10.2147/OTT.S334205

By:

Yu, Zhe;
Wei, Wei;
Liu, Hongruo;
Pan, Evenki;
Yang, Peng;
Jiang, Kui

Publication type:

Article

Stomatitis And Everolimus: A Review Of Current Literature On 8,201 Patients.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 9669, doi. 10.2147/OTT.S195121

By:

Arena, Claudia;
Troiano, Giuseppe;
Zhurakivska, Khrystyna;
Nocini, Riccardo;
Muzio, Lorenzo Lo

Publication type:

Article